Therapeutics Advances
Copyright ©The Author(s) 2015.
World J Surg Proced. Nov 28, 2015; 5(3): 217-222
Published online Nov 28, 2015. doi: 10.5412/wjsp.v5.i3.217
Table 1 Characteristics of the series of 57 patients n (%)
Age (yr)57, 8.9 SD
Status menstrual
Premenopausal13 (22.8)
Postmenopausal44 (77.2)
Affected breast
Right19 (33.3)
Left38 (66.7)
Tumour location through the breast (quadrant)
Upper outer16 (28.1)
Upper inner3 (5.3)
Lower Inner3 (5.3)
Central12 (21.1)
Intersection upper quadrants7 (12.3)
Intersection lower quadrants5 (8.8)
Intersection inner quadrants3 (5.3)
Intersection outer quadrants7 (12.3)
Inframmary fold1 (1.8)
Multifocal14 (24.6)
Radiological tumour size (mm)21.7, 12.58 SD
Table 2 Characteristic of 57 breast carcinomas n (%)
In situ7 (12.3)
Invasive50 (87.7)
Type of histology
Ductal39
Lobular6
Mixed1
Papilar1
Others3
Positive estrogenic receptors38
Positive progesterone receptors37
Positive Herb2 receptors7
Ki67 (n = 42)
> 10%15
10%-50%19
51%-75%3
> 75%4
Pathologic tumour size (mm)17.1, 9.77 SD
Patients with lymph nodes positives12 (14)